Raymond Khoury
AUTHOR

Raymond Khoury

Tap the gear icon above to manage new release emails.
Raymond Khoury is the Sunday Times bestselling author of six thrillers, starting with his debut novel, THE LAST TEMPLAR. Raymond came to writing thrillers from a career in screenwriting, which includes the BAFTA award winning BBC series SPOOKS (aka MI:5 in the US) and Waking The Dead. It partly explains why his novels are often described as cinematic and very visual. As fellow bestselling author Steve Berry puts it: "His expertly chosen verbs cause the scenes to leap from the page. You can literally feel the blows as they're landed; wince as the bullets find their marks. He has an intense brand of storytelling all his own." Raymond's thrillers are based on big themes that interest him such as international politics and conspiracies, fact vs faith, why we age and die, what do we really know about reincarnation, about mind control. He explores these themes in depth, with heavy emphasis on research, and often combines a historical angle to his stories. As such, some of his novels (THE LAST TEMPLAR, THE SANCTUARY, THE TEMPLAR SALVATION, RASPUTIN'S SHADOW) feature dual timelines: the bulk of the stories are set in the present day, interspersed with chapters that take place in the distant past. As Booklist puts it, "Khoury's thrillers engage the reader's mind, even as they move at a breakneck pace. Readers who like their thrillers to have a solid intellectual component will enjoy Khoury's books very much. Given the high quality of each of his novels, it seems fair to say that he may be around for a while." Raymond's new thriller, THE END GAME, is released by Orion in hardback and ebook on March 10, 2016. To find out more about him and his work, visit his website at raymondkhoury.com or connect with him on his Facebook page.
Read more Read less

Best Sellers

Product List
  • Tempelriddernes hemmelighed cover art

    ₹267.00 or free with 30-day trial

    Free with 30-day trial
  • Scriptum cover art

    ₹434.00 or free with 30-day trial

    Free with 30-day trial